EMA’s 2026 hands-on EudraVigilance training says participants should be able to apply ISO/ICH E2B(R3) rules to spontaneous and follow-up reports, amendment and nullification reports, parent-child cases, and clinical-trial SUSAR examples. The agenda also includes EVWEB use for creating, sending, accessing, and querying ICSRs.
That matters for careers because it shows these are not legacy skills being phased out. They remain part of the active competence framework surrounding EU pharmacovigilance reporting. Professionals who can work confidently with E2B(R3) logic and EVWEB still hold practical value in the market.
In a changing industry, fundamentals still create leverage. Often, they create the foundation for using newer digital tools well. That last point is an inference from the continuing emphasis EMA places on these skills.
0 Comments